AIQ Global, Inc. dba AIQ Solutions
AIQ Solutions is a passionate group of entrepreneurs, scientists, and engineers dedicated to improving treatment outcomes for patients with complex diseases worldwide. They leverage intellectual property and clinical validation to innovate and change how clinicians manage complex diseases, especially in late-stage cancer care. Their software, cleared by the FDA for clinical use, provides novel information for therapy adjustment and outcome optimization, focusing on treatment response heterogeneity and personalized medicine.
Industries
Nr. of Employees
small (1-50)
AIQ Global, Inc. dba AIQ Solutions
Madison, Wisconsin, United States, North America
Products
Lesion-level longitudinal quantitative imaging software (510(k)-cleared)
A clinical software medical device that analyzes serial radiographic images to quantify changes in regions of interest over time and produces reports intended to support oncologist decision-making.
Lesion-level longitudinal quantitative imaging software (510(k)-cleared)
A clinical software medical device that analyzes serial radiographic images to quantify changes in regions of interest over time and produces reports intended to support oncologist decision-making.
Services
Cloud-based lesion-level image analysis and reporting
Remote processing of serial PET/CT (and other radiographic) studies to produce quantitative lesion-level metrics and clinician-facing reports delivered via secure cloud workflows.
Research collaborations and clinical validation support
Collaborative programs for biomarker development, retrospective study analysis, and clinical validation of imaging-derived predictive metrics, including support funded through grants for immunotherapy response prediction.
Platform integration with research data management systems
Integration and deployment services to connect imaging analysis pipelines with cloud-scale research data management and collaboration platforms to enable scalable workflows.
Cloud-based lesion-level image analysis and reporting
Remote processing of serial PET/CT (and other radiographic) studies to produce quantitative lesion-level metrics and clinician-facing reports delivered via secure cloud workflows.
Research collaborations and clinical validation support
Collaborative programs for biomarker development, retrospective study analysis, and clinical validation of imaging-derived predictive metrics, including support funded through grants for immunotherapy response prediction.
Platform integration with research data management systems
Integration and deployment services to connect imaging analysis pipelines with cloud-scale research data management and collaboration platforms to enable scalable workflows.
Expertise Areas
- Imaging biomarker development
- Quantitative image analysis and radiomics
- Longitudinal lesion-level response assessment
- AI/ML-driven predictive analytics for treatment response
Key Technologies
- PET/CT imaging analysis
- Radiomics and lesion heterogeneity metrics
- Longitudinal lesion tracking
- AI / machine learning for predictive modeling